Establishing China's national standards of antigen content and neutralizing antibody responses for evaluation of enterovirus 71 (EV71) vaccines
Open Access
- 1 December 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (52), 9668-9674
- https://doi.org/10.1016/j.vaccine.2011.10.018
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- EV71: An emerging infectious disease vaccine target in the Far East?Vaccine, 2010
- Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against DiseaseJournal of Virology, 2010
- The molecular basis of mouse adaptation by human enterovirus 71Journal of General Virology, 2008
- Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challengeVaccine, 2008
- Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptideMicrobes and Infection, 2007
- Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptidesVirus Research, 2007
- Expression, purification and characterization of enterovirus-71 virus-like particlesWorld Journal of Gastroenterology, 2006
- Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virusVaccine, 2001
- Comparison of enterovirus 71 and coxsackievirus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998The Pediatric Infectious Disease Journal, 1999
- An Apparently New Enterovirus Isolated from Patients with Disease of the Central Nervous SystemThe Journal of Infectious Diseases, 1974